HireQuest (HQI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
11 May, 2026Financial performance and growth
Maintained net income positivity every year since 2002, excluding one-time transaction fees and expenses.
System-wide sales grew 1.8x, adjusted EBITDA 1.5x, and adjusted EPS 2.6x from 2019 to 2025.
Total market share increased 85% between 2019 and 2025, with total sales up 56.9%.
Demonstrated resilience, with staffing sales declining only 6.1% from industry peak in 2022 to 2025, compared to a 27.4% industry decline.
Pro forma adjusted EBITDA reached $14.7m in 2025, up from $10.0m in 2019.
Strategic initiatives and capital allocation
Completed over 15 M&A transactions since 2019, spending $77m in cash and generating $29m from resale of acquired locations.
Paid $18m in dividends and executed $9m in share buybacks since 2019.
Maintained low leverage, with $0 debt at the end of 2025 and maximum leverage of 0.9x since 2019.
Fully diluted shares increased only 2.4% from 2019 to 2025, minimizing shareholder dilution.
Franchise model and operational advantages
Franchise model delivers high-margin, less volatile royalty revenue compared to traditional staffing.
Streamlined cost structure as franchisees manage branch operations, reducing corporate overhead.
Franchisees drive local strategy, supported by centralized tools and resources.
Enables rapid integration of acquisitions and generates incremental cash flow through resale to franchisees.
Provides consistent profitability and downside protection across economic cycles.
Latest events from HireQuest
- Shareholders will vote on directors, auditor ratification, and executive pay, with robust governance.HQI
Proxy filing30 Apr 2026 - Profitability held steady as revenue fell, with improved working capital and strategic restructuring.HQI
Q4 202530 Mar 2026 - All director, auditor, and compensation proposals were approved; no questions were raised.HQI
AGM 20243 Feb 2026 - Profitability held steady as revenue declined, with optimism for recovery and ongoing M&A focus.HQI
Q2 20242 Feb 2026 - Q3 2024 saw 1.6% revenue growth, a $6M impairment loss, and stronger adjusted earnings.HQI
Q3 202415 Jan 2026 - Profitability and strong margins maintained in Q4 2024 despite revenue and sales declines.HQI
Q4 202426 Dec 2025 - Board recommends approval of all proxy proposals, emphasizing governance and oversight.HQI
Proxy Filing1 Dec 2025 - Revenue and earnings declined, but profitability and liquidity remained strong.HQI
Q2 202524 Nov 2025 - Revenue and net income fell, but profitability and liquidity remained strong amid industry headwinds.HQI
Q1 202521 Nov 2025